Authors' Reply
Overview
Affiliations
Bortezomib in autoimmune hemolytic anemia and beyond.
Pasquale R, Giannotta J, Barcellini W, Fattizzo B Ther Adv Hematol. 2021; 12:20406207211046428.
PMID: 34795889 PMC: 8593301. DOI: 10.1177/20406207211046428.
Comparison of N-methyl-D-aspartate receptor antibody assays using live or fixed substrates.
Thouin A, Gastaldi M, Woodhall M, Jacobson L, Vincent A J Neurol. 2021; 268(5):1818-1826.
PMID: 33389029 DOI: 10.1007/s00415-020-10329-0.
An Update on the Treatment of Pediatric Autoimmune Encephalitis.
Stingl C, Cardinale K, Van Mater H Curr Treatm Opt Rheumatol. 2018; 4(1):14-28.
PMID: 29780690 PMC: 5957495. DOI: 10.1007/s40674-018-0089-z.
Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.
Shin Y, Lee S, Kim T, Jun J, Chu K Ann Clin Transl Neurol. 2018; 5(5):598-605.
PMID: 29761122 PMC: 5945964. DOI: 10.1002/acn3.557.
Treatment strategies for autoimmune encephalitis.
Shin Y, Lee S, Park K, Jung K, Jung K, Lee S Ther Adv Neurol Disord. 2018; 11:1756285617722347.
PMID: 29399043 PMC: 5784571. DOI: 10.1177/1756285617722347.